Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.

Khansur E, Shah AH, Lacy K, Komotar RJ.

Cancer Invest. 2019;37(1):1-7. doi: 10.1080/07357907.2018.1479414. Epub 2019 Jan 11. Review.

PMID:
30632816
2.

Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.

Khansur EM, Shah AH, Lacy K, Kuchakulla M, Komotar RJ.

Cureus. 2018 Jan 30;10(1):e2130. doi: 10.7759/cureus.2130. Review.

3.

Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.

Maxwell R, Jackson CM, Lim M.

Curr Treat Options Oncol. 2017 Aug;18(8):51. doi: 10.1007/s11864-017-0492-y. Review.

PMID:
28785997
4.

Advances in Immunotherapy for Glioblastoma Multiforme.

Huang B, Zhang H, Gu L, Ye B, Jian Z, Stary C, Xiong X.

J Immunol Res. 2017;2017:3597613. doi: 10.1155/2017/3597613. Epub 2017 Feb 19. Review.

5.

Vaccine-Based Immunotherapeutics for the Treatment of Glioblastoma: Advances, Challenges, and Future Perspectives.

Cuoco JA, Benko MJ, Busch CM, Rogers CM, Prickett JT, Marvin EA.

World Neurosurg. 2018 Dec;120:302-315. doi: 10.1016/j.wneu.2018.08.202. Epub 2018 Sep 6. Review.

PMID:
30196171
6.

Emerging immunotherapies for glioblastoma.

Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH.

Expert Opin Emerg Drugs. 2016 Jun;21(2):133-45. doi: 10.1080/14728214.2016.1186643. Review.

7.

Heat shock proteins in glioblastomas.

Yang I, Fang S, Parsa AT.

Neurosurg Clin N Am. 2010 Jan;21(1):111-23. doi: 10.1016/j.nec.2009.09.002. Review.

PMID:
19944971
8.

[Immunotherapy in brain tumors].

De Carli E, Delion M, Rousseau A.

Ann Pathol. 2017 Feb;37(1):117-126. doi: 10.1016/j.annpat.2016.12.001. Epub 2017 Jan 19. Review. French.

PMID:
28111040
9.

Dendritic cell immunotherapy for malignant gliomas.

Luptrawan A, Liu G, Yu JS.

Rev Recent Clin Trials. 2008 Jan;3(1):10-21. Review.

PMID:
18474011
10.

Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma.

Sinnadurai M, McDonald KL.

J Neurooncol. 2017 May;132(3):359-372. doi: 10.1007/s11060-017-2390-3. Epub 2017 Mar 14. Review.

PMID:
28293764
11.

Heat shock protein vaccines against glioblastoma: from bench to bedside.

Ampie L, Choy W, Lamano JB, Fakurnejad S, Bloch O, Parsa AT.

J Neurooncol. 2015 Jul;123(3):441-8. doi: 10.1007/s11060-015-1837-7. Epub 2015 Jun 21. Review.

12.

Tumor Vaccines for Malignant Gliomas.

Srinivasan VM, Ferguson SD, Lee S, Weathers SP, Kerrigan BCP, Heimberger AB.

Neurotherapeutics. 2017 Apr;14(2):345-357. doi: 10.1007/s13311-017-0522-2. Review.

13.

Immunotherapy approaches in the treatment of malignant brain tumors.

Dunn-Pirio AM, Vlahovic G.

Cancer. 2017 Mar 1;123(5):734-750. doi: 10.1002/cncr.30371. Epub 2016 Nov 22. Review.

14.

Current challenges in designing GBM trials for immunotherapy.

Weathers SP, Gilbert MR.

J Neurooncol. 2015 Jul;123(3):331-7. doi: 10.1007/s11060-015-1716-2. Epub 2015 Jan 11. Review.

PMID:
25577401
15.

Vaccine-based immunotherapy for glioblastoma.

Thomas AA, Fisher JL, Ernstoff MS, Fadul CE.

CNS Oncol. 2013 Jul;2(4):331-49. doi: 10.2217/cns.13.29. Review.

16.

Therapeutic Immunization against Glioblastoma.

Schijns VEJC, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FPK, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A.

Int J Mol Sci. 2018 Aug 27;19(9). pii: E2540. doi: 10.3390/ijms19092540. Review.

17.

Dendritic cell immunotherapy for glioblastoma.

Polyzoidis S, Ashkan K.

Expert Rev Anticancer Ther. 2014 Jul;14(7):761-3. doi: 10.1586/14737140.2014.921571. Epub 2014 May 21.

PMID:
24850137
18.

Immunological challenges for peptide-based immunotherapy in glioblastoma.

Mohme M, Neidert MC, Regli L, Weller M, Martin R.

Cancer Treat Rev. 2014 Mar;40(2):248-58. doi: 10.1016/j.ctrv.2013.08.008. Epub 2013 Sep 8. Review.

19.

Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.

Sengupta S, Thaci B, Crawford AC, Sampath P.

Biomed Res Int. 2014;2014:952128. doi: 10.1155/2014/952128. Epub 2014 Aug 27. Review.

20.

[Peptide vaccination in glioblastoma].

Terasaki M, Morioka M.

Gan To Kagaku Ryoho. 2014 Jun;41(6):725-9. Japanese. No abstract available.

PMID:
25167577

Supplemental Content

Support Center